Tetrahydrobenzazepine derivatives useful as modulators of dopamine D3 receptors (antipsychotic agents)
AssigneeSmithKline Beecham Corporation
InventorsMichael Stewart Hadley, Christopher Norbert Johnson, Gregor James MacDonald, Geoffrey Stemp, Antonio Kuok Keong Vong
Life of this patent
Estimating the term…
Abstract
Compounds of Formula I and their salts having affinity for dopamine receptors, in particular the D3 Receptor, and thus potential in the treatment of conditions wherein modulation of the D3 receptor is beneficial, e.g., as antipsychotic agents.
Claims21
A compound of formula (I):
- wherein:
- R1 represents a substituent selected from:
- a hydrogen or halogen atom;
- a hydroxy, cyano, nitro, trifluoromethyl, trifluoromethoxy, trifluoromethanesulfonyloxy, pentafluoroethyl, C1-4alkyl, C1-4alkoxy, arylC1-4alkoxy, C1-4alkylthio, C1-4alkoxyC1-4alkyl, C3-6cycloalkylC1-4alkoxy, C1-4alkanoyl, C1-4alkoxycarbonyl, C1-4alkylsulfonyl, C1-4alkylsulfonyloxy, C1-4alkylsulfonylC1-4alkyl, arylsulfonyl, arylsulfonyloxy, arylsulfonylC1-4alkyl, C1-4alkylsulfonamido, C1-4alkylamido, C1-4alkylsulfonamidoC1-4alkyl, C1-4alkylamidoC1-4alkyl, arylsulfonamido, arylcarboxamido, arylsulfonamidoC1-4alkyl, arylcarboxamidoC1-4alkyl, aroyl, aroylC1-4alkyl, or arylC1-4alkanoyl group;
- a group R3OCO(CH2)p, R3CON(R4)(CH2)p, R3R4NCO(CH2)p or R3R4NSO2(CH2)p where each of R3 and R4 independently represents a hydrogen atom or a C1-4alkyl group or R3R4 forms part of a C3-6azacyloalkane or C3-6(2-oxo)azacycloalkane ring and p represents zero or an integer from 1 to 4;
- or a group Ar3—Z, wherein Ar3 represents an optionally substituted phenyl ring or an optionally substituted 5- or 6-membered aromatic heterocyclic ring and Z represents a bond, O, S or CH2;
- R2 represents a hydrogen atom or a C1-4alkyl group;
- q is 1 or 2;
- A represents a group of the formula (a), (b), (c) or (d):
- wherein
- Ar represents an optionally substituted phenyl ring or an optionally substituted 5- or 6-membered aromatic heterocyclic ring;
- or an optionally substituted bicyclic ring system;
- Ar1 and Ar2 each independently represent an optionally substituted phenyl ring or an optionally substituted 5- or 6-membered aromatic heterocyclic ring;
- and
- Y represents a bond, —NHCO—, —CONH—, —CH2—, or —(CH2)mY1(CH2)n—, wherein Y1 represents O, S, SO2, or CO and m and n each represent zero or 1 such that the sum of m+n is zero or 1;
- providing that when A represents a group of formula (a), any substituent present in Ar ortho to the carboxamide moiety is necessarily a hydrogen or a methoxy group;
- r and s independently represent an integer from zero to 3 such that the sum of r and s is equal to an integer from 1 to 4;
- and
- V represents a bond, O or S;
- or a salt thereof.
A compound or salt as claimed in claim 13 wherein R1 is defined as follows:
- (a) when R1 represents an arylC1-4alkoxy, arylsulfonyl, arylsulfonyloxy, arylsulfonylC1-4alkyl, arylsulfonamido, arylcarboxamido, arylsulfonamidoC1-4alkyl, arylcarboxamidoC1-4alkyl, aroyl, aroylC1-4alkyl, or arylC1-4alkanoyl group, the aryl moiety is selected from an optionally substituted phenyl ring or an optionally substituted 5- or 6-membered heterocyclic ring;
- and
- (b) wherein, in the group R1 any aryl moiety is optionally substituted by one or more substituents selected from hydrogen, halogen, amino, cyano, C1-4alkyl, C1-4alkylamino, C1-4dialkylamino, C1-4alkanoyl, or R5R6NCO where each of R5 and R6 independently represents a hydrogen atom or C1-4alkyl group.
A compound according to formula (I), wherein the compound is trans-3-(2-(1-(4-(3-(3-(5-Methyl)-1,2,4-oxadiazolyl)benzoyl)amino)-cyclohexyl)ethyl)-7-methylsulphonyl-2,3,4,5-tetrahydro-1H-3-benzazepine or a salt thereof.
A compound according to formula (I), wherein the compound is trans-3-(2-(1-(4-(3-(2-(4-Methyl)oxazolyl)benzoyl)amino)-cyclohexyl)ethyl)-7-methylsulphonyl-2,3,4,5-tetrahydro-1H-3-benzazepine or a salt thereof.
A compound according to formula (I), wherein the compound is trans-3-(2-(1-(4-(3-(2-(5-Methyl)oxazolyl)benzoyl)amino)-cyclohexyl)ethyl)-7-methylsulphonyloxy-2,3,4,5-tetrahydro-1H-3-benzazepine or a salt thereof.
A compound according to formula (I), wherein the compound is trans-(E)-7-(3-(5-Methyl)-1,2,4-oxadiazolyl)-3-(2-(1-(4-(3-(4-fluoro)phenylpropenoyl)amino)cyclohexyl)ethyl)-2,3,4,5-tetrahydro-1H-3-benzazepine, which is the compound of the formula
- or a salt thereof.
A compound which is:
- trans-3-(2-(1-(4-(N-tert-Butyloxycarbonyl)amino)cyclohexyl)ethyl)-7-methylsulphonyl-2,3,4,5-tetrahydro-1H-3-benzazepine, or
- trans-3-(2-(1-(4-Amino)cyclohexyl)ethyl)-7-methylsulphonyl-2,3,4,5-tetrahydro-1H-3-benzazepine.
Dependencies are inferred from the claim text.